Total Funding
51
59
Total FundingPost-IPO Debt raised
Growth Score 51 in past quarter
-20 pts
Heat Score 59 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68186
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class
William Rice: President & Chief Executive OfficerPast Role: Achillion Pharmaceuticals, Founder, President, CEO, Director
Fletcher Payne: Senior Vice President, Chief Business Officer & Chief Financial OfficerPast Role: Aptose Biosciences, Senior Vice President & Chief Financial Officer
About the Company
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to
clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.

